FMA
MDCO

FNY Managed Accounts’s Medicines Co MDCO Stock Holding History

FNY Managed Accounts’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,000
Closed -$75.5K – 341
2016
Q3 		$75.5K Buy
+2,000
New +$75.4K 0.06% 173

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

FNY Managed Accounts's MDCO Position: Q4 2016 in Review

FNY Managed Accounts sold out of Medicines Co (MDCO) in Q4 2016, closing a stake of 2,000 shares — an estimated $75.5K sold.

FNY Managed Accounts first reported a position in MDCO in Q3 2016 and held it in 1 quarter. The position peaked at $75.5K in Q3 2016. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

  • FNY Managed Accounts reported no remaining Medicines Co position as of Q4 2016 after selling out during the quarter.
  • FNY Managed Accounts sold 2,000 Medicines Co shares in Q4 2016, an estimated $75.5K.
  • FNY Managed Accounts first reported a position in Medicines Co in Q3 2016 and held it in 1 quarter.
  • FNY Managed Accounts's Medicines Co position peaked at $75.5K in Q3 2016.
  • 195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on FNY Managed Accounts's 13F filing for Q4 2016, filed 8 Feb 2017.